{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:41Z","timestamp":1790692061250,"version":"4.1.0"},"reference-count":157,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The landscape of attitudes, legal status and patterns of use of cannabis is rapidly changing in the United States and elsewhere. Therefore, the primary aim of this narrative review is to provide a concise overview of the literature on the comorbidity of cannabis use and cannabis use disorder (CUD) with other substance use and psychiatric disorders, and to use this information to accurately guide future directions for the field. Methods: A literature review of PubMed was conducted for studies relating to cannabis use, CUD, and a co-occurring psychiatric disorder. To provide an overview of representative data, the literature review focused on national-level, population-based work from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) and National Survey on Drug Use and Health (NSDUH) surveys. Considering rapidly changing cannabis laws, recent (past five-year) studies were addressed. Results: A strong body of literature shows associations between cannabis use and CUD with other drug use, psychosis, mood disorders, anxiety disorders, and personality disorders. The strongest evidence of a potential causal relationship exists between cannabis use and psychotic disorders. While some evidence shows potential directionality between cannabis use and mood and anxiety disorders, results are inconsistent. Studies have established higher rates of CUD among those with personality disorders, but little about the specifics of this relationship is understood. Conclusions: Although the general population in the United States increasingly perceives cannabis to be a harmless substance, empirical evidence shows that cannabis use is associated both with CUD and comorbid psychiatric illness. However, there is mixed evidence regarding the role of cannabis in the etiology, course, and prognosis of a co-occurring disorder across all categories of psychiatric disorders. Future research should expand on the existing body of literature with representative, longitudinal data, in order to better understand the acute and long-term effects of cannabis on comorbid psychiatric illness.<\/jats:p>","DOI":"10.3390\/jcm10010015","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T08:38:43Z","timestamp":1608712723000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review"],"prefix":"10.3390","volume":"10","author":[{"given":"Deborah","family":"Hasin","sequence":"first","affiliation":[{"name":"New York State Psychiatric Institute, New York, NY 10032, USA"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Walsh","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"ref_1","unstructured":"National Institute on Drug Abuse (2020, August 11). Marijuana Research Report, Available online: https:\/\/www.drugabuse.gov\/download\/1380\/marijuana-research-report.pdf."},{"key":"ref_2","unstructured":"Substance Abuse Center for Behavioral Health Statistics and Quality (2020, August 11). Results from the 2018 National Survey on Drug Use and Health: Detailed Tables, Available online: https:\/\/www.samhsa.gov\/data\/report\/2018-nsduh-detailed-tables."},{"key":"ref_3","unstructured":"DISA Global Solutions (2020, August 11). Map of Marijuana Legality by State. Available online: https:\/\/disa.com\/map-of-marijuana-legality-by-state."},{"key":"ref_4","unstructured":"United Nations Office on Drug and Crime (2020, August 11). World Drug Report 2019: Executive Summary. Available online: https:\/\/wdr.unodc.org\/wdr2019\/prelaunch\/WDR19_Booklet_1_EXECUTIVE_SUMMARY.pdf."},{"key":"ref_5","unstructured":"(2020, August 11). Seizures of Drugs in England and Wales, Financial Year Ending 2019 Second Edition, Available online: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/870323\/seizures-drugs-mar2019-hosb3119.pdf."},{"key":"ref_6","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2020, August 11). Cannabis Legalisation in Europe: An Overview. Available online: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4135\/TD0217210ENN.pdf."},{"key":"ref_7","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2020, August 11). Cannabis Policy: Status and Recent Developments. Available online: https:\/\/www.emcdda.europa.eu\/publications\/topic-overviews\/cannabis-policy\/html_en."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jadohealth.2012.07.010","article-title":"Individual and country-level effects of cannabis-related perceptions on cannabis use. A multilevel study among adolescents in 32 European countries","volume":"52","author":"Piontek","year":"2013","journal-title":"J. Adolesc. Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","article-title":"Cannabis use, attitudes, and legal status in the U.S.: A review","volume":"104","author":"Carliner","year":"2017","journal-title":"Prev. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/dta.1506","article-title":"The adverse health effects of chronic cannabis use","volume":"6","author":"Hall","year":"2014","journal-title":"Drug Test. Anal."},{"key":"ref_11","first-page":"1922","article-title":"Adverse Effects of Cannabis on Adolescent Brain Development: A Longitudinal Study","volume":"27","author":"Camchong","year":"2017","journal-title":"Cereb. Cortex."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/2589977511666180809165622","article-title":"Is Cannabis Harmless? Focus on Brain Function","volume":"11","author":"Ashton","year":"2019","journal-title":"Curr. Drug Res. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US Epidemiology of Cannabis Use and Associated Problems","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of Marijuana Use Disorders in the United States Between 2001\u20132002 and 2012\u20132013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New trends in cannabis potency in USA and Europe during the last decade (2008\u20132017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamapsychiatry.2020.0339","article-title":"Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?","volume":"77","author":"Murray","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1017\/S0033291717003877","article-title":"Changes in cannabis potency and first-time admissions to drug treatment: A 16-year study in the Netherlands","volume":"48","author":"Freeman","year":"2018","journal-title":"Psychol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/add.14525","article-title":"Increasing potency and price of cannabis in Europe, 2006\u20132016","volume":"114","author":"Freeman","year":"2019","journal-title":"Addiction"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2006.06.003","article-title":"Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol","volume":"86","author":"Wagner","year":"2007","journal-title":"Drug Alcohol. Depend."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jamapsychiatry.2017.0724","article-title":"US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991\u20131992 to 2012\u20132013","volume":"74","author":"Hasin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/dar.12183","article-title":"Factors associated with the timing and onset of cannabis use and cannabis use disorder: Results from the 2007 Australian National Survey of Mental Health and Well-Being","volume":"33","author":"Butterworth","year":"2014","journal-title":"Drug Alcohol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ypmed.2017.06.026","article-title":"Commentary: Navigating the complexities of marijuana","volume":"104","author":"Weiss","year":"2017","journal-title":"Prev. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-440X(85)90073-2","article-title":"Alcohol and drug abuse in patients with affective syndromes","volume":"26","author":"Hasin","year":"1985","journal-title":"Compr. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archpsyc.1984.01790230064010","article-title":"The clinician\u2019s illusion","volume":"41","author":"Cohen","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012\u20132013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00127-015-1088-0","article-title":"The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: Review and summary of findings","volume":"50","author":"Hasin","year":"2015","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2014.12.011","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample","volume":"148","author":"Hasin","year":"2015","journal-title":"Drug Alcohol. Depend."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.61.4.361","article-title":"Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.59.9.794","article-title":"Major depression in 6050 former drinkers: Association with past alcohol dependence","volume":"59","author":"Hasin","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions","volume":"64","author":"Compton","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100903","DOI":"10.1016\/j.arr.2019.04.005","article-title":"Multimorbidity and quality of life: Systematic literature review and meta-analysis","volume":"53","author":"Makovski","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychires.2015.05.004","article-title":"Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: An analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC)","volume":"66\u201367","author":"Cougle","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.copsyc.2017.09.006","article-title":"Impact of personality pathology on psychosocial functioning","volume":"21","author":"Skodol","year":"2018","journal-title":"Curr. Opin. Psychol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11136-005-8661-z","article-title":"Relationship between multimorbidity and health-related quality of life of patients in primary care","volume":"15","author":"Fortin","year":"2006","journal-title":"Qual. Life Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S0033291706008361","article-title":"Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity","volume":"36","author":"Stinson","year":"2006","journal-title":"Psychol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/da.22947","article-title":"Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study","volume":"36","author":"Bilevicius","year":"2019","journal-title":"Depress. Anxiety"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.euroneuro.2017.06.004","article-title":"DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample","volume":"27","author":"Hayley","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.psychres.2019.05.041","article-title":"The association between cannabis use and psychiatric comorbidity in people with personality disorders: A population-based longitudinal study","volume":"278","author":"Shalit","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/add.14883","article-title":"Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005\u20132017: The role of differentially changing risk perceptions","volume":"115","author":"Pacek","year":"2020","journal-title":"Addiction"},{"key":"ref_45","unstructured":"National Center for Biotechnology Information (2020, December 10). PubMed User Guide, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/help\/#:~:text=Last%20Update%3A%20March%2031%2C%202020.&text=PubMed%20comprises%20over%2030%20million,science%20journals%2C%20and%20online%20books."},{"key":"ref_46","unstructured":"Grant, B.F., and Dawson, D.A. (2020, August 11). Introduction to the National Epidemiologic Survey on Alcohol and Related Conditions, Available online: https:\/\/pubs.niaaa.nih.gov\/publications\/arh29-2\/74-78.htm."},{"key":"ref_47","unstructured":"National Institute on Alcohol Abuse and Alcoholism (2020, August 11). National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III), Available online: https:\/\/www.niaaa.nih.gov\/research\/nesarc-iii."},{"key":"ref_48","unstructured":"Substance Abuse and Mental Health Services Administration (2020, August 11). NSDUH: About the Survey. Available online: https:\/\/nsduhweb.rti.org\/respweb\/about_nsduh.html."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"107867","DOI":"10.1016\/j.drugalcdep.2020.107867","article-title":"Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012\u20132017","volume":"208","author":"Gukasyan","year":"2020","journal-title":"Drug Alcohol. Depend."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"107894","DOI":"10.1016\/j.drugalcdep.2020.107894","article-title":"Cannabis use among youth in the United States, 2004\u20132016: Faster rate of increase among youth with depression","volume":"209","author":"Weinberger","year":"2020","journal-title":"Drug Alcohol. Depend."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/0020764018795213","article-title":"Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015","volume":"64","author":"Carra","year":"2018","journal-title":"Int. J. Soc. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/dar.12964","article-title":"Medical and non-medical cannabis use and risk of prescription opioid use disorder: Findings from propensity score matching","volume":"38","author":"Liang","year":"2019","journal-title":"Drug Alcohol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11121-018-0908-3","article-title":"When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes","volume":"20","author":"Fairman","year":"2019","journal-title":"Prev. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2018.02.037","article-title":"Nicotine dependence predicts cannabis use disorder symptoms among adolescents and young adults","volume":"187","author":"Dierker","year":"2018","journal-title":"Drug Alcohol. Depend."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/tobaccocontrol-2018-054590","article-title":"Cigarette smoking quit ratios among adults in the USA with cannabis use and cannabis use disorders, 2002\u20132016","volume":"29","author":"Weinberger","year":"2020","journal-title":"Tob. Control"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2017.12.007","article-title":"Correlates and trends in youth co-use of marijuana and tobacco in the United States, 2005\u20132014","volume":"185","author":"Schauer","year":"2018","journal-title":"Drug Alcohol. Depend."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.addbeh.2015.05.012","article-title":"Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003\u20132012","volume":"49","author":"Schauer","year":"2015","journal-title":"Addict. Behav."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2215-0366(14)70307-4","article-title":"Young adult sequelae of adolescent cannabis use: An integrative analysis","volume":"1","author":"Silins","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugpo.2014.07.011","article-title":"Probability and predictors of the cannabis gateway effect: A national study","volume":"26","author":"Jin","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1360-0443.2005.01322.x","article-title":"Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis","volume":"101","author":"Fergusson","year":"2006","journal-title":"Addiction"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1176\/appi.ajp.2017.17040413","article-title":"Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States","volume":"175","author":"Olfson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ajad.12260","article-title":"Concomitant cannabis abuse\/dependence in patients treated with opioids for non-cancer pain","volume":"24","author":"Hefner","year":"2015","journal-title":"Am. J. Addict."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/00952990.2019.1607363","article-title":"Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only","volume":"45","author":"Sofuoglu","year":"2019","journal-title":"Am. J. Drug Alcohol. Abuse"},{"key":"ref_64","unstructured":"Gorfinkel, L., Stohl, M., Greenstein, E., Aharonovich, E., Olfson, M., and Hasin, D. (2020). Is cannabis substituted for non-medical opioids? Using daily measurements to assess the strength of the association between cannabis and opioid use. Addiction, in press."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.addbeh.2011.02.012","article-title":"Predictors and consequences of simultaneous alcohol and cannabis use in adolescents","volume":"36","author":"Briere","year":"2011","journal-title":"Addict. Behav."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"378","DOI":"10.15288\/jsad.2014.75.378","article-title":"Alcohol and marijuana use patterns associated with unsafe driving among U.S. high school seniors: High use frequency, concurrent use, and simultaneous use","volume":"75","author":"Johnston","year":"2014","journal-title":"J. Stud. Alcohol. Drugs"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1530-0277.1996.tb01953.x","article-title":"Polydrug use in adolescent drinkers with and without DSM-IV alcohol abuse and dependence","volume":"20","author":"Martin","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/acer.12698","article-title":"Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey","volume":"39","author":"Subbaraman","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s40429-017-0149-8","article-title":"Co-use of Alcohol and Cannabis: A Review","volume":"4","author":"Yurasek","year":"2017","journal-title":"Curr. Addict. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/schbul\/sbx056","article-title":"Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population","volume":"43","author":"Chang","year":"2017","journal-title":"Schizophr. Bull."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","article-title":"Size of burden of schizophrenia and psychotic disorders","volume":"15","author":"Rossler","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/15504263.2019.1674991","article-title":"Cannabis Use and the Risk for Psychosis and Affective Disorders","volume":"16","author":"Sideli","year":"2020","journal-title":"J. Dual. Diagn"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia","volume":"93","author":"Brown","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study","volume":"6","author":"Quattrone","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1017\/S0033291706008440","article-title":"Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999","volume":"36","author":"Boydell","year":"2006","journal-title":"Psychol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Hjorthoj, C., Larsen, M.O., Starzer, M.S.K., and Nordentoft, M. (2019). Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016. Psychol. Med., 1\u20136.","DOI":"10.1017\/S0033291719003532"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e1813","DOI":"10.1002\/mpr.1813","article-title":"Psychotic disorders hospitalizations associated with cannabis abuse or dependence: A nationwide big data analysis","volume":"29","author":"Braganca","year":"2020","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2017.06.018","article-title":"Cannabis-associated psychosis: Neural substrate and clinical impact","volume":"124","author":"Murray","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-analysis","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref_81","first-page":"6380","article-title":"Cannabinoids and Psychosis","volume":"22","author":"Radhakrishnan","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2215-0366(20)30074-2","article-title":"Psychiatric symptoms caused by cannabis constituents: A systematic review and meta-analysis","volume":"7","author":"Hindley","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2215-0366(19)30176-2","article-title":"High-potency cannabis and incident psychosis: Correcting the causal assumption\u2014Authors\u2019 reply","volume":"6","author":"Morgan","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00127-020-01831-x","article-title":"The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Programme","volume":"55","author":"Jongsma","year":"2020","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/acps.12847","article-title":"Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: An umbrella review of meta-analyses","volume":"137","author":"Belbasis","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ijnp\/pyaa031","article-title":"Psychosis-relevant effects of intravenous delta-9-tetrahydrocannabinol\u2014A mega analysis of individual participant-data from human laboratory studies","volume":"23","author":"Ganesh","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/schbul\/sbi027","article-title":"The environment and schizophrenia: The role of cannabis use","volume":"31","author":"Henquet","year":"2005","journal-title":"Schizophr. Bull."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis: A longitudinal population-based study","volume":"156","author":"Bak","year":"2002","journal-title":"Am. J. Epidemiol"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/mp.2014.51","article-title":"Genetic predisposition to schizophrenia associated with increased use of cannabis","volume":"19","author":"Power","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1360-0443.2005.01001.x","article-title":"Tests of causal linkages between cannabis use and psychotic symptoms","volume":"100","author":"Fergusson","year":"2005","journal-title":"Addiction"},{"key":"ref_92","unstructured":"Murray, R.M., and Stilo, S.A. (2003). Gene-Environment Interactions. The Epidemiology of Schizophrenia, Cambridge University Press."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/08039488.2019.1622152","article-title":"The influence of substance use on the effectiveness of antipsychotic medication: A prospective, pragmatic study","volume":"73","author":"Alisauskiene","year":"2019","journal-title":"Nord. J. Psychiatry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2017.06.039","article-title":"Demographic and clinical correlates of substance use disorders in first episode psychosis","volume":"194","author":"Brunette","year":"2018","journal-title":"Schizophr. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/15504263.2016.1252075","article-title":"Routine Drug Screening for Patients in the Emergency Department of a State Psychiatric Hospital: A Naturalistic Cohort Study","volume":"12","author":"Margolis","year":"2016","journal-title":"J. Dual Diagn."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Priede","year":"2012","journal-title":"Schizophr. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1017\/S0033291717000046","article-title":"Cannabis use and adherence to antipsychotic medication: A systematic review and meta-analysis","volume":"47","author":"Foglia","year":"2017","journal-title":"Psychol. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2215-0366(17)30233-X","article-title":"Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: A prospective analysis","volume":"4","author":"Schoeler","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr. Bull."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study","volume":"2","author":"Marconi","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.psychres.2017.05.009","article-title":"Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis","volume":"255","author":"Schoeler","year":"2017","journal-title":"Psychiatry Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Livne, O., Shmulewitz, D., Sarvet, A., and Hasin, D. (2020). Association of cannabis use-related predictor variables and self-reported psychotic disorders: US adults, 2001\u20132002 and 2012\u20132013. medRxiv.","DOI":"10.1101\/2020.09.25.20201871"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/schbul\/sbq079","article-title":"The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample","volume":"38","author":"Yucel","year":"2012","journal-title":"Schizophr. Bull."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291715001646","article-title":"The effects of cannabis on memory function in users with and without a psychotic disorder: Findings from a combined meta-analysis","volume":"46","author":"Schoeler","year":"2016","journal-title":"Psychol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jsat.2011.12.010","article-title":"Comorbid depression and substance use disorder: Longitudinal associations between symptoms in a controlled trial","volume":"43","author":"Worley","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/YCO.0000000000000257","article-title":"The natural history of substance use disorders","volume":"29","author":"Sarvet","year":"2016","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/YCO.0b013e3282f32408","article-title":"Major depression and comorbid substance use disorders","volume":"21","author":"Davis","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/08897077.2018.1550464","article-title":"Trends of major depressive episode among people with cannabis use: Findings from the National Survey on Drug Use and Health 2006\u20132015","volume":"40","author":"Carra","year":"2019","journal-title":"Subst. Abuse"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2017.02.027","article-title":"Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study","volume":"251","author":"Feingold","year":"2017","journal-title":"Psychiatry Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.09.005","article-title":"DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults","volume":"195","author":"Livne","year":"2019","journal-title":"Drug Alcohol. Depend."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4088\/JCP.v69n0902","article-title":"Cannabis withdrawal in the United States: Results from NESARC","volume":"69","author":"Hasin","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.addbeh.2008.02.001","article-title":"Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence","volume":"33","author":"Cornelius","year":"2008","journal-title":"Addict. Behav."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jad.2017.02.016","article-title":"Patterns of marijuana use among psychiatry patients with depression and its impact on recovery","volume":"213","author":"Bahorik","year":"2017","journal-title":"J. Affect. Disord."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2018.05.065","article-title":"Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization","volume":"241","author":"Bahorik","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2015.02.009","article-title":"Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race\/ethnicity","volume":"149","author":"Pacek","year":"2015","journal-title":"Drug Alcohol. Depend."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e2013802","DOI":"10.1001\/jamanetworkopen.2020.13802","article-title":"Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016","volume":"3","author":"Gorfinkel","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10519-017-9848-0","article-title":"Cannabis and Depression: A Twin Model Approach to Co-morbidity","volume":"47","author":"Smolkina","year":"2017","journal-title":"Behav. Genet."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S0033291713001438","article-title":"The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies","volume":"44","author":"Roerecke","year":"2014","journal-title":"Psychol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/00952990.2012.694523","article-title":"Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia","volume":"38","author":"Lai","year":"2012","journal-title":"Am. J. Drug Alcohol. Abuse"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.addbeh.2015.05.014","article-title":"Gender differences in the associations among marijuana use, cigarette use, and symptoms of depression during adolescence and young adulthood","volume":"49","author":"Crane","year":"2015","journal-title":"Addict. Behav."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.psychres.2012.12.014","article-title":"Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates","volume":"209","author":"McKenzie","year":"2013","journal-title":"Psychiatry Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.psy.0000151489.36347.18","article-title":"Psychiatric and medical comorbidities of bipolar disorder","volume":"67","author":"Krishnan","year":"2005","journal-title":"Psychosom. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neubiorev.2019.04.004","article-title":"The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression","volume":"101","author":"Pinto","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1176\/appi.ajp.2009.09020299","article-title":"Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: Prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"167","author":"Ostacher","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"ref_128","unstructured":"National Institute of Mental Health (2020, August 11). Prevalence of Any Anxiety Disorder Among Adults, Available online: https:\/\/www.nimh.nih.gov\/health\/statistics\/any-anxiety-disorder.shtml."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","article-title":"Adverse effects of cannabis","volume":"352","author":"Hall","year":"1998","journal-title":"Lancet"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00052-0","article-title":"Cannabis use and anxiety in daily life: A naturalistic investigation in a non-clinical population","volume":"118","author":"Tournier","year":"2003","journal-title":"Psychiatry Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12967-020-02518-2","article-title":"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties","volume":"18","author":"Sharpe","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Orsolini, L., Chiappini, S., Volpe, U., Berardis, D., Latini, R., Papanti, G.D., and Corkery, A.J.M. (2019). Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina, 55.","DOI":"10.3390\/medicina55090525"},{"key":"ref_134","first-page":"1","article-title":"Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: A nationwide longitudinal VA study","volume":"46","author":"Sofuoglu","year":"2020","journal-title":"Am. J. Drug Alcohol. Abuse"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2017.162","article-title":"Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder","volume":"43","author":"Hill","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Metrik, J., Stevens, A.K., Gunn, R.L., Borsari, B., and Jackson, K.M. (2020). Cannabis use and posttraumatic stress disorder: Prospective evidence from a longitudinal study of veterans. Psychol. Med., 1\u201311.","DOI":"10.1017\/S003329172000197X"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.drugalcdep.2011.12.023","article-title":"The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC)","volume":"124","author":"Buckner","year":"2012","journal-title":"Drug Alcohol. Depend."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1521-0391.2014.12150.x","article-title":"Cannabis and related impairment: The unique roles of cannabis use to cope with social anxiety and social avoidance","volume":"23","author":"Buckner","year":"2014","journal-title":"Am. J. Addict."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1081\/ADA-120015873","article-title":"Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence","volume":"28","author":"Agosti","year":"2002","journal-title":"Am. J. Drug Alcohol. Abuse"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.drugalcdep.2006.12.013","article-title":"Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents","volume":"88","author":"Wittchen","year":"2007","journal-title":"Drug Alcohol. Depend."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1360-0443.2012.04015.x","article-title":"The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood","volume":"108","author":"Degenhardt","year":"2013","journal-title":"Addiction"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/10826084.2014.984851","article-title":"Association between personality disorders traits and problematic cannabis use in adolescents","volume":"50","author":"Chabrol","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/add.14209","article-title":"Associations between personality disorders and cannabis use and cannabis use disorder: A population-based twin study","volume":"113","author":"Gillespie","year":"2018","journal-title":"Addiction"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.addbeh.2016.04.018","article-title":"Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults","volume":"60","author":"Raynal","year":"2016","journal-title":"Addict. Behav."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addbeh.2018.06.015","article-title":"Borderline personality disorder features and drinking, cannabis, and prescription opioid motives: Differential associations across substance and sex","volume":"87","author":"Vest","year":"2018","journal-title":"Addict. Behav."},{"key":"ref_146","unstructured":"American Medical Association (2020, December 10). The National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. Available online: https:\/\/newmexico.networkofcare.org\/content\/client\/1446\/2.6_17_AsamNationalPracticeGuidelines.pdf."},{"key":"ref_147","unstructured":"ProCon (2020). Legal Medical Marijuana States and DC, Encyclopaedia Britannica."},{"key":"ref_148","unstructured":"Moon, A., and Prentice, C. (2017). High Tech, High Finance and High Times for U.S. Pot Industry. Reuters, Thomson Reuters Corporation."},{"key":"ref_149","unstructured":"Dsouza, D. (2020). The Future of the Marijuana Industry in America. Investopedia, IAC Media Company."},{"key":"ref_150","unstructured":"Evans, P. (2019). 8 Incredible Facts about the Booming US Marijuana Industry. Business Insider, Insider Inc."},{"key":"ref_151","unstructured":"Center for Responsive Politics (2020, August 11). Industry Profile: Marijuana. Available online: https:\/\/www.opensecrets.org\/federal-lobbying\/industries\/summary?cycle=2019&id=N09."},{"key":"ref_152","unstructured":"Branfalt, T.G. (2020, August 11). Cannabis Industry Spent $11M on Federal Lobbying in 2019. Available online: https:\/\/www.ganjapreneur.com\/cannabis-industry-spent-11m-on-federal-lobbying-in-2019\/."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jhealeco.2015.03.007","article-title":"The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances","volume":"42","author":"Wen","year":"2015","journal-title":"J. Health Econ."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2016.10.004","article-title":"State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population","volume":"169","author":"Martins","year":"2016","journal-title":"Drug Alcohol. Depend."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamapsychiatry.2019.3254","article-title":"Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016","volume":"77","author":"Cerda","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling Accuracy of Cannabidiol Extracts Sold Online","volume":"318","author":"Loflin","year":"2017","journal-title":"JAMA"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"107993","DOI":"10.1016\/j.drugalcdep.2020.107993","article-title":"The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda","volume":"212","author":"Loflin","year":"2020","journal-title":"Drug Alcohol. Depend."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:48:48Z","timestamp":1760179728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":157,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["jcm10010015"],"URL":"https:\/\/doi.org\/10.3390\/jcm10010015","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]}}}